AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
26 hedge funds and large institutions have $372K invested in Agile Therapeutics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $683K → $372K (-$311K)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$32K | |
| 2 | +$10.8K | |
| 3 | +$5.02K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.28K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3.01K |
Top Sellers
| 1 | -$158K | |
| 2 | -$29K | |
| 3 | -$26.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 5 |
Jane Street
New York
|
-$5.56K |